Skip to main content

Tofisopam (International)



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Anxiolytic agent

Benzodiazepine derivative

Chemical Name

5H-2,3-Benzodiazepin, 1-(3,4-dimetoxyphenyl)-5-etyl-7,8-dimetoxy-4-metyl-

Foreign Names

  • Tofisopamum (Latin)
  • Tofisopam (German)
  • Tofisopam (French)
  • Tofisopam (Spanish)

Generic Names

  • Tofisopam (OS: JAN, DCF)
  • EGYT 341 (IS)
  • Tofisopam (PH: JP XVII)

Brand Names

  • Grandaxin
    Egis, Bulgaria; Egis, Georgia; Egis, Lithuania; Egis, Latvia; Egis, Serbia; Egis, Russian Federation; Egis, Slovakia; Egis Pharmaceuticals, Romania; Egis Praha, Czech Republic; Medimpex, Pakistan; Mochida Pharmaceutical, Japan; Searle, Egypt
  • Grandaxin 10%
    Mochida Pharmaceutical, Japan
  • Grandaxin 50 mg
    Egis, Hungary
  • Granpam
    Towa Yakuhin, Japan
  • Isotan
    Hanlim, South Korea
  • No Deprine
    Alphamoun, Egypt
  • Tofisopam
    Nichi-Iko Pharmaceutical, Japan; Nihon Generic, Japan; Sawai Seiyaku, Japan
  • Tofisopam 10%
    Choseido Pharmaceutical, Japan; Tsuruhara Seiyaku Pharmaceutical, Japan


DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.